Molecular genetic alterations in ductal pancreatic adenocarcinomas.
about
5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissuePathways for aberrant angiogenesis in pancreatic cancerCritical role of NF-κB in pancreatic cancerTCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesisPrimers on molecular pathways. The glycogen synthase kinase-3betaDevelopment of orthotopic pancreatic tumor mouse modelsConcomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.Screening for pancreatic cancer: current evidence and future directions.Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-RasDuctal pancreatic cancer in humans and mice.Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profilePancreatic adenocarcinoma: new strategies for successPancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth.Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells.
P2860
Q24685466-AED809F4-2A37-442C-88D9-D6D6A6A3924BQ24800215-92B65B6C-6DAC-4172-A39E-1FBFAB908385Q26864198-CD6E216C-B248-418E-BFA5-8F238C0EEF4CQ30908891-4C428037-1B26-4578-A3CD-7AC1672726E7Q33301293-69AEA487-B110-44F1-8E91-9D996F0E977FQ33726528-A1A1845D-00C3-4BC8-9A4D-B324F3760565Q34326442-A8ADD5F4-CE1D-471F-A364-C2DED8A7E1ECQ35014007-8CD00A4E-F896-4BDA-8462-3F09B80BDE67Q36182661-AD500A36-5482-4CA0-AFE1-8B0B960D3582Q36547707-F8C49907-7360-498E-B1D5-7F6FB3530015Q36817494-FF5B5692-6540-4C7A-9DC1-809CE74C6DDFQ37198628-294DB306-ED59-4284-BC08-F3AE6D736C95Q37410628-0ED5D24E-82A2-4C34-A7E2-689E99D1A014Q38332130-B459FC3E-A234-4B18-91D1-D1075A6C8ED3Q38674749-A9DC80A9-4325-4E80-A3C9-2118F8AD5AB9Q39784275-D49C9B31-C778-4A28-A27A-8DF4F2A8DFAFQ40228737-116DEECA-CA5E-4EB1-8489-034EC0FD2A0FQ40631284-CC735427-839C-42B1-9DDD-6B1AF2D738BC
P2860
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@ast
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@en
type
label
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@ast
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@en
prefLabel
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@ast
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@en
P1476
Molecular genetic alterations in ductal pancreatic adenocarcinomas.
@en
P2093
P304
P356
10.1016/S0025-7125(05)70251-0
P577
2000-05-01T00:00:00Z